SOLASCURE LIMITED
Company number 10826246 · Monitor this company
Executive summary
SolasCure Limited occupies a strategically attractive position in the growing chronic wound care market, underpinned by a £3.5M patent portfolio and Cambridge-based R&D capabilities, but faces an existential cash constraint with only £810K remaining and £22.7M in accumulated losses. The next 12-18 months represent a critical window: the company must secure non-dilutive funding through grants and licensing partnerships, or raise additional capital, to bridge the gap between current burn and commercial revenue. Success hinges on executing a capital-efficient path to regulatory milestones that unlock partnership value before liquidity pressures force suboptimal decisions.
Shareholders' funds
-£23,714,311
Balance sheet as at 2026-06-30
What it does
The principal activity of the Company during the financial year was developing wound care products that significantly improve the health and wellbeing of patients with chronic wounds.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-06-20
- Employees
- 9 (2026 accounts · was 10 in 2025)
- Registered office
- Wellington House, East Road, Cambridge, England, CB1 1BH
- Postcode
- CB1 1BH
- Capital
- 20 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2026-06-30
- Next due by
- 2028-03-31
- Financial year end
- 30 June
Confirmation statement
- Last statement dated
- 2025-09-12
- Next due by
- 2026-09-26
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 9 current · 6 resigned
Contact details
- Website
- solascure.com
- Phone
- +44 1223827959
Previous company names
| Name | Date changed |
|---|---|
| AURASE LIMITED | 2018-02-13 |
Previous registered addresses 2
| Address | Changed on |
|---|---|
| CEFN COED UNIT 1, CEFN COED, NANTGARW, CARDIFF, CF15 7QQ, WALES | 2020-09-01 |
| 52 SOUTH PARK HILL ROAD, SOUTH CROYDON, CR2 7DW, UNITED KINGDOM | 2018-06-23 |
Competitors Cambridge
This company ranks 229 among research and experimental development on biotechnology in Cambridge.
The class of 2017
37%
of the 435 companies in this sector incorporated in 2017 are still active today; 61% have since been dissolved.
A fact about the year, not a forecast for this company.